[1]
Linares MA, Zakaria A, Nizran P. Skin cancer. Prim Care 2015; 42(4): 645-59.
[http://dx.doi.org/10.1016/j.pop.2015.07.006]
[http://dx.doi.org/10.1016/j.pop.2015.07.006]
[2]
Leiter U. Epidemiology of skin cancer. Adv Exp Med Biol 2014; 810: 120-40.
[http://dx.doi.org/10.1007/978-1-4939-0437-2_7]
[http://dx.doi.org/10.1007/978-1-4939-0437-2_7]
[3]
Ahmad N. A comparative ex vivo permeation evaluation of a novel 5-Fluorocuracil nanoemulsion-gel by topically applied in the different excised rat, goat, and cow skin. Saudi J Biol Sci 2020; 27(4): 1024-40.
[4]
Nagwanshi P. Emphasis of Phytoconstituent in the treatment of cancer. Res J Pharma Dosage Forms Tech 2020; 12(3): 169-77.
[http://dx.doi.org/10.5958/0975-4377.2020.00029.4]
[http://dx.doi.org/10.5958/0975-4377.2020.00029.4]
[5]
Nivelle L. Cytotoxicity of labruscol, a new resveratrol dimer produced by grapevine cell suspensions, on human skin melanoma cancer cell line HT-144. Molecules 2017; 22(11): 1940.
[http://dx.doi.org/10.3390/molecules22111940]
[http://dx.doi.org/10.3390/molecules22111940]
[6]
Kumar A. Potential role of resveratrol and its nano-formulation as anti-cancer agent. Explor Target Antitumor Ther 2022; 3(5): 643-58.
[http://dx.doi.org/10.37349/etat.2022.00105]
[http://dx.doi.org/10.37349/etat.2022.00105]
[7]
Juin SK, Ghosh S, Majumdar S. Glycyrrhizic acid facilitates anti-tumor immunity by attenuating Tregs and MDSCs: An immunotherapeutic approach. Int Immunopharmacol 2020; 88: 106932.
[http://dx.doi.org/10.1016/j.intimp.2020.106932]
[http://dx.doi.org/10.1016/j.intimp.2020.106932]
[8]
Cherng J-M. Molecular mechanisms underlying chemopreventive activities of glycyrrhizic acid against UVB-radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Radiat Res 2011; 176(2): 177-86.
[http://dx.doi.org/10.1667/RR2510.1]
[http://dx.doi.org/10.1667/RR2510.1]